Viader A, Sasaki Y, Kim S, Strickland A, Workman CS, Yang K, et al
For GLP-1 medications, insurers may require evidence that the patient has tried other treatments or that the medication is essential for managing weight loss in the presence of other conditions like type 2 diabetes, hypertension, or cardiovascular disease
Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus
FUNDING RC is recipient of a fellowship from CAPES
Coordination with employers and case managers on duty restrictions, light-duty assignments, and return-to-work timing
Referencias bibliogrficas Longo, N., Frigeni, M., & Pasquali, M